Results 221 to 230 of about 15,997 (285)

Charting Water‐in‐Natural‐Salt (WiNS) Electrolytes. Part I: Effect of Anion's Alkyl Tail Length

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
At 20 m, potassium carboxylates from formate to butyrate reveal anion tail‐controlled nanostructure. SAXS shows a pre‐peak shifting to lower q with chain length. Molecular dynamics reproduces S(q) and attributes it to concentration fluctuations forming bicontinuous segregation.
Alessandra Del Giudice, Laura Hildebrandt, Jin Han, Radhika Krishna Hema, Luciano Galantini, Stefano Passerini, Alberto Varzi, Alessandro Mariani   +7 more
wiley   +1 more source

Low‐Dimensional Materials and Van Der Waals Heterostructures for Energy Application: A Comprehensive Review

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Low‐dimensional materials (0D, 1D, and 2D) exhibit unique electronic and physicochemical properties, enabling advanced nanoelectronic and optoelectronic devices. Mixed‐dimensional heterostructures combine these materials to enhance functionality.
Qaisar Alam, Sajjad Ali, Pir Muhammad Ismail, ABM Sharif Hossain   +3 more
wiley   +1 more source

Patient data for commercial companies? An ethical framework for sharing patients' data with for-profit companies for research. [PDF]

J Med Ethics
Winkler EC, Jungkunz M, Thorogood A, Lotz V, Schickhardt C.   +4 more
europepmc   +1 more source

The Ecological U‐Turn in Nordic Forestry: Policy Learning, Measurement, and the Retrenchment of Ecological Ambitions

Environmental Policy and Governance, EarlyView.
ABSTRACT Since the 1990s, environmental policy has shifted toward ecosystem protection and biodiversity conservation, a development often described as an ecological turn. This article argues that in practice this turn has taken the form of an ecological “U‐turn,” as environmental ambitions are subordinated to production‐oriented objectives.
Gisle Andersen, Monika Berg, Hogne Lerøy Sataøen   +2 more
wiley   +1 more source

Assessing tuberculosis stigma: a pooled multi-country descriptive analysis of 17 high-burden countries using a standardised tool. [PDF]

Front Public Health
Mok WMP, Malar J, Soltan V, Smyth C, Ul Eman K, Subakti A, Lobo R, Mukuhwa T, Tobaiwa D, Lunga M, Denysenko V, Kayowa B, Garcia D, Chamreun CS.   +13 more
europepmc   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Informed Consent as a Human Right in the Inter-American Human Rights System (IAHRS). [PDF]

Dev World Bioeth
Bernal-Camargo DR, Gómez-Córdoba AI.
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

When Activism Becomes Survival: The Mental Health Costs of Constant Resistance in the Digital Era in the Balkans-A Health Policy Perspective. [PDF]

J Mark Access Health Policy
Sič A, Mijuskovic S, Brezic N.
europepmc   +1 more source